Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26 USD | -0.31% | +1.60% | -16.10% |
Financials (USD)
Sales 2024 * | 355M | Sales 2025 * | 501M | Capitalization | 3.86B |
---|---|---|---|---|---|
Net income 2024 * | -725M | Net income 2025 * | -674M | EV / Sales 2024 * | 12.5 x |
Net Debt 2024 * | 554M | Net Debt 2025 * | 656M | EV / Sales 2025 * | 9.01 x |
P/E ratio 2024 * |
-5.62
x | P/E ratio 2025 * |
-6.63
x | Employees | 912 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.91% |
Latest transcript on Insmed Incorporated
1 day | -0.31% | ||
1 week | +1.60% | ||
Current month | +5.18% | ||
1 month | -7.51% | ||
3 months | -9.00% | ||
6 months | +9.47% | ||
Current year | -16.10% |
Managers | Title | Age | Since |
---|---|---|---|
Will Lewis
CEO | Chief Executive Officer | 55 | 12-09-09 |
Sara Bonstein
DFI | Director of Finance/CFO | 43 | 20-01-30 |
Martina Flammer
CTO | Chief Tech/Sci/R&D Officer | 60 | 19-12-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 20-03-31 |
Al Altomari
BRD | Director/Board Member | 65 | 12-08-01 |
Melvin Sharoky
BRD | Director/Board Member | 73 | 01-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.26% | 0 M€ | 0.00% | - | |
0.25% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 26 | -0.31% | 1,901,715 |
24-05-07 | 26.08 | +0.50% | 1,195,332 |
24-05-06 | 25.95 | +1.57% | 1,394,893 |
24-05-03 | 25.55 | -0.43% | 1,259,050 |
24-05-02 | 25.66 | +0.27% | 1,504,178 |
Delayed Quote Nasdaq, May 08, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.10% | 3.86B | |
+2.93% | 108B | |
+7.02% | 23.46B | |
-14.60% | 21.72B | |
-7.05% | 18.64B | |
-38.55% | 17.45B | |
-8.83% | 17.19B | |
+5.51% | 13.99B | |
+37.49% | 12.53B | |
+329.39% | 8.81B |
- Stock Market
- Equities
- INSM Stock